Conference Coverage

Biogen’s aducanumab stumbles on cognitive endpoints at 6 mg/kg dose

Publish date: July 23, 2015

 

FROM AAIC 2015

References

msullivan@frontlinemedcom.com

On Twitter @Alz_Gal

Pages

Recommended Reading

Physical Fitness and Brain Health
MDedge Neurology
Is Diabetes a Cause of Dementia?
MDedge Neurology
Alberto Ramos, MD
MDedge Neurology
Herpes Simplex Virus 1 and Alzheimer Disease
MDedge Neurology
Mixed pathologies are very common in black Alzheimer’s patients
MDedge Neurology
AAIC: Sedentary early adulthood may mean worse cognitive functioning later
MDedge Neurology
VIDEO: Dementia risk doubled in type 1 diabetes patients
MDedge Neurology
VIDEO: Investigating the role of plasmalogens in Alzheimer’s disease
MDedge Neurology
Estrogen therapy linked to brain atrophy in women with diabetes
MDedge Neurology
VIDEO: Postoperative cognitive decline hits women hardest
MDedge Neurology